Stage IVA Oropharyngeal Squamous Cell Carcinoma Active Not Recruiting Phase 1 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0039579 (Stage IVA Oropharyngeal Squamous Cell Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01254617Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerTreatment
NCT01935921Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerTreatment